These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Hepatic acetylator polymorphism in breast cancer patients.
    Author: Ladero JM, Fernández MJ, Palmeiro R, Muñoz JJ, Jara C, Lázaro C, Pérez-Manga G.
    Journal: Oncology; 1987; 44(6):341-4. PubMed ID: 3684174.
    Abstract:
    Hepatic acetylator phenotype has been determined, using sulfamethazine, in 81 white Spanish women with histologically proven breast cancer and in 75 adequate female controls. No differences were detected in the distribution of acetylator phenotype between the two groups of slow acetylators, 49 patients (60.5%) and 45 controls (60%). The percentage of acetylated sulfamethazine in plasma for each phenotype was not different either. Our results suggest that there is no relationship between the hepatic acetylator polymorphism and the risk of developing breast cancer in women.
    [Abstract] [Full Text] [Related] [New Search]